Erythrophleum is a genus of approximately ten to twelve species of trees in the family Fabaceae (legume family), order Fabales, subfamily Caesalpinioideae. The genus was described by the Swedish botanist Adam Afzelius and formally published by George Don in Genera Historia Plantarum (1832).
Members of the genus are medium to large deciduous or semi-deciduous trees, typically reaching 15–30 metres in height, with boles up to 90 centimetres in diameter. The heartwood is dense, very hard, and durable — resistant to fungi, termites, and dry wood borers — making these trees commercially valuable timber sources. Species in the genus have root nodules that fix atmospheric nitrogen.
The genus has a disjunct distribution across the tropics: most species occur in sub-Saharan Africa (from West Africa east to Sudan and south to Zimbabwe and Mozambique), while others are native to Indochina, southern China, and northern Australia. African species such as E. suaveolens (Sasswood Tree) and E. ivorense favour moist semi-deciduous forests, gallery forests, and wooded grasslands. The Australian species E. chlorostachys (Cooktown ironwood) occurs from north-eastern Queensland to the Kimberley in Western Australia, in habitats ranging from arid savanna to tropical rainforest margins.
All parts of Erythrophleum species contain potent diterpenoid alkaloids, including cassaine and norcassamidine. In high doses the bark extract is a rapid-acting cardiac poison — causing seizures and cardiac arrest in warm-blooded animals — and the foliage of E. chlorostachys has caused significant livestock mortality in Australia. The toxic bark of African species has long been used as an ordeal poison, in arrow poisons, and as fish poison. Paradoxically, dilute bark preparations have a long history of medicinal use in Africa: as emetics and purgatives, as anthelmintics, and externally for pain. In the late 19th century, bark extracts were trialled in Europe as a treatment for heart failure, analogous in action to digitoxin, before being abandoned due to side effects.
Etymology
The genus name Erythrophleum is derived from the Greek erythros (“red”) and phloios (“bark”), referring to the reddish bark characteristic of many species. The name was established by Adam Afzelius and published by George Don in 1832.
Distribution
The genus spans three major tropical regions: most species occur across sub-Saharan Africa from Sierra Leone east to Sudan and south to Mozambique and Zimbabwe, favouring moist semi-deciduous forests and gallery forests up to 1,100 m elevation. Additional species occur in Indochina, southern China, and Southeast Asia (E. fordii, E. succirubrum, E. teysmannii). The Australian species E. chlorostachys (Cooktown ironwood) is endemic to northern Australia, ranging from north-eastern Queensland to the Kimberley in Western Australia across savanna, monsoon forest, and rainforest margins to 500 m.
Ecology
Species occupy a range of tropical habitats: African members grow in moist semi-deciduous forests, gallery forests, and wooded grasslands, and are absent from closed evergreen forest; E. chlorostachys occurs across arid savanna, monsoon forest, and rainforest margins. All species possess root-nodule bacteria capable of fixing atmospheric nitrogen — an asset in poor soils, though leaf mulch from E. suaveolens has shown allelopathic effects on nearby crops. The foliage and bark of all species contain cytotoxic and cardiotoxic alkaloids; E. chlorostachys foliage has been responsible for widespread livestock fatalities in northern Australia.
Cultural Uses
African species — particularly E. suaveolens — have a long and complex relationship with human culture. The bark, containing potent alkaloids, was historically prepared as an ordeal poison used in judicial trials across West and Central Africa; accused individuals were forced to drink a bark decoction, with survival interpreted as proof of innocence. The bark and leaves were also used as fish poisons and incorporated into arrow poisons. Medicinally, bark decoctions have been used across Africa as emetics, purgatives, anthelmintics, and local anaesthetics, and the bark reached European pharmacopeias in the 19th century as a cardiac agent. The Australian E. chlorostachys holds significance for Aboriginal communities: “sugar bag scars” on trunks — cut to access native bee honey — are culturally significant markers of past practice on Cape York Peninsula, and hollows at Kakadu National Park are regarded as likely culturally modified trees.
History
Erythrophleum was described by Adam Afzelius, a Swedish botanist who collected in West Africa, and formally published by George Don in Genera Historia Plantarum volume 2, page 424, in 1832. In the late 19th century, bark extracts of E. suaveolens were exported to Europe and investigated as a treatment for heart failure, given an action analogous to digitoxin; the practice was abandoned after side effects and the superior efficacy of digitoxin ended its clinical use.
